New Whitepaper Compares Targeted Resequencing Strategies
News Jul 17, 2013
Oxford Gene Technology (OGT) has produced a new, free-to-download whitepaper titled ‘When to use targeted resequencing - Choosing the right NGS method.’
The paper aims to assist researchers when planning NGS strategies by providing a detailed review of the major resequencing methods.
Comparing and contrasting method suitability, the paper also examines the significant impact of data analysis, as well as time and cost considerations.
OGT has written the whitepaper in response to a growing demand from within its customer base and the NGS community for a balanced and comprehensive guide to targeted resequencing strategies.
Considered from both clinical research and discovery viewpoints, the paper discusses whole exome and targeted panel sequencing strategies, without bias.
This includes highlighting the limitations of each approach, and offering advice on when whole genome sequencing is appropriate, providing researchers with insight to identify the most suitable method for the task at hand.
Considerations are also presented on choice of capture technologies, bait design and the use of service providers for method optimization and accessibility to meaningful results.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019
4th Annual Congress on Nanomedicine and Drug Delivery
Apr 04 - Apr 06, 2019